Search

Your search keyword '"Izuhara, Kenji"' showing total 1,101 results

Search Constraints

Start Over You searched for: Author "Izuhara, Kenji" Remove constraint Author: "Izuhara, Kenji"
1,101 results on '"Izuhara, Kenji"'

Search Results

4. Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis

5. Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: A prospective, observational study

6. A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib

12. Further evidence for association of YKL-40 with severe asthma airway remodeling

18. Serum IgG4 as a biomarker reflecting pathophysiology and post-operative recurrence in chronic rhinosinusitis

21. A novel pathophysiologic link between upper and lower airways in patients with chronic rhinosinusitis: Association of sputum periostin levels with upper airway inflammation and olfactory function

23. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis

24. Cytokine Network

29. Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease

30. Mechanisms of tissue degeneration mediated by periostin in spinal degenerative diseases and their implications for pathology and diagnosis: a review

32. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

33. The ability of biomarkers to assess the severity of atopic dermatitis

39. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis

42. Staphylococcus aureus enterotoxin sensitization involvement and its association with the CysLTR1 variant in different asthma phenotypes

45. The ability of biomarkers to assess the severity of atopic dermatitis

46. Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol

48. Dupilumab Improves Long‐term Outcomes in Patients With Uncontrolled, Moderate‐to‐Severe GINA‐Based Type 2 Asthma, Irrespective of Allergic Status

50. Pretreatment Frequency of Circulating Th17 Cells and FeNO Levels Predicted the Real-World Response after 1 Year of Benralizumab Treatment in Patients with Severe Asthma

Catalog

Books, media, physical & digital resources